1. Home
  2. NTIC vs IFRX Comparison

NTIC vs IFRX Comparison

Compare NTIC & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTIC
  • IFRX
  • Stock Information
  • Founded
  • NTIC 1970
  • IFRX 2007
  • Country
  • NTIC United States
  • IFRX Germany
  • Employees
  • NTIC N/A
  • IFRX N/A
  • Industry
  • NTIC Industrial Specialties
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTIC Industrials
  • IFRX Health Care
  • Exchange
  • NTIC Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • NTIC 121.6M
  • IFRX 143.7M
  • IPO Year
  • NTIC N/A
  • IFRX 2017
  • Fundamental
  • Price
  • NTIC $12.90
  • IFRX $2.54
  • Analyst Decision
  • NTIC Buy
  • IFRX Strong Buy
  • Analyst Count
  • NTIC 1
  • IFRX 1
  • Target Price
  • NTIC $20.00
  • IFRX $8.00
  • AVG Volume (30 Days)
  • NTIC 26.0K
  • IFRX 174.5K
  • Earning Date
  • NTIC 01-08-2025
  • IFRX 11-08-2024
  • Dividend Yield
  • NTIC 2.17%
  • IFRX N/A
  • EPS Growth
  • NTIC 52.91
  • IFRX N/A
  • EPS
  • NTIC 0.52
  • IFRX N/A
  • Revenue
  • NTIC $86,216,235.00
  • IFRX $187,930.00
  • Revenue This Year
  • NTIC $11.04
  • IFRX $392.79
  • Revenue Next Year
  • NTIC $8.10
  • IFRX $156.76
  • P/E Ratio
  • NTIC $24.81
  • IFRX N/A
  • Revenue Growth
  • NTIC 7.59
  • IFRX 177.12
  • 52 Week Low
  • NTIC $11.70
  • IFRX $1.17
  • 52 Week High
  • NTIC $19.63
  • IFRX $2.82
  • Technical
  • Relative Strength Index (RSI)
  • NTIC 43.11
  • IFRX 56.66
  • Support Level
  • NTIC $12.70
  • IFRX $2.16
  • Resistance Level
  • NTIC $13.41
  • IFRX $2.65
  • Average True Range (ATR)
  • NTIC 0.62
  • IFRX 0.24
  • MACD
  • NTIC -0.05
  • IFRX -0.01
  • Stochastic Oscillator
  • NTIC 26.67
  • IFRX 63.33

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: